Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
AstraZeneca
Fuji
Citi
Julphar

Generated: May 27, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208686

« Back to Dashboard

NDA 208686 describes EPANED, which is a drug marketed by Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug and two Paragraph IV challenges. Additional details are available on the EPANED profile page.

The generic ingredient in EPANED is enalapril maleate. There are twenty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.
Summary for 208686
Tradename:EPANED
Applicant:Silvergate Pharms
Ingredient:enalapril maleate
Patents:4
Formulation / Manufacturing:see details
Pharmacology for NDA: 208686
Medical Subject Heading (MeSH) Categories for 208686
Suppliers and Packaging for NDA: 208686
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPANED enalapril maleate SOLUTION;ORAL 208686 NDA Silvergate Pharmaceuticals, Inc. 52652-4001 52652-4001-1 150 mL in 1 BOTTLE (52652-4001-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength1MG/ML
Approval Date:Sep 20, 2016TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Mar 25, 2036Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 25, 2036Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING HYPERTENSION
Patent:➤ Try a Free TrialPatent Expiration:Mar 25, 2036Product Flag?Substance Flag?Delist Request?
Patented Use:METHOD OF TREATING LEFT VENTRICULAR DYSFUNCTION

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
Queensland Health
Merck
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.